Skip to main content
Log in

Hyperhomocysteinemia independently associated with the risk of hypertension: a cross-sectional study from rural China

  • Original Article
  • Published:
Journal of Human Hypertension Submit manuscript

Abstract

This study was designed to investigate the current prevalence of hyperhomocysteinemia (Hhcy) and its association with hypertension in rural adults of Northeast China. A cross-sectional study was performed in subjects aged⩾35 years in a general Chinese population. Demographic data, laboratory examination of traditional cardiovascular risk factors and self-reported information on lifestyle factors, such as physical activities, current smoking and drinking status, dietary habits and familial factors were collected by trained personnel. A total of 7130 participants (3317 men and 3813 women) were included in this study and the mean Hhcy level of the whole population was 17.39±12.34 mmol l−1, which was 20.99±14.83 mmol l−1 in males and 14.19±8.51 mmol l−1 in females, respectively. Prevalence of Hhcy in total population was 41.3%. Stratified by gender, the prevalence of Hhcy was higher in males than in females (59.0 vs 25.8%, P<0.05). After adjustment for conventional risk factors including age, salt intake, smoking, body mass index, diabetes, dyslipidemia, activity time and family history, multiple logistic regression analysis showed that Hhcy was independently associated with the risk of hypertension in males (odds ratio (OR)=1.501, 95% confidence interval (CI): 1.012–2.227; P<0.001), but not in females in this population (OR=1.182; 95% CI, 0.993–1.407; P=0.060). In conclusion, a high prevalence of Hhcy in the general adult population of rural northeast China was detected and Hhcy may be a risk factor for hypertension, particularly in males.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Chow CK, Teo KK, Rangarajan S, Islam S PURE (Prospective Urban Rural Epidemiology) Study investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310 (9): 959–968.

    Article  CAS  Google Scholar 

  2. Naureen A, Munazza B, Shaheen R, Khan SA, Fatima F . Serum homocysteine as a risk factor for coronary heart disease. J Ayub Med Coll Abbottabad 2012; 24 (1): 59–62.

    PubMed  Google Scholar 

  3. Sobol AB, Bald E, Loba J . Fractions of total plasma homocysteine in patients with ischemic stroke before the age of 55 years. Angiology 2005; 56 (2): 201–209.

    Article  Google Scholar 

  4. Lim U, Cassano PA . Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2002; 156 (12): 1105–1113.

    Article  Google Scholar 

  5. Sutton-Tyrrell K, Bostom A, Selhub J, Zeigler-Johnson C . High Homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation 1997; 96 (6): 1745–1749.

    Article  CAS  Google Scholar 

  6. Dinavahi R, Cossrow N, Kushner H, Falkner B . Plasma homocysteine concentration and blood pressure in young adult African Americans. Am J Hypertens 2003; 16 (9 Pt 1): 767–770.

    Article  CAS  Google Scholar 

  7. Fakhrzadeh H, Ghotbi S, Pourebrahim R, Nouri M, Heshmat R, Bandarian F et al. Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study. BMC Public Health 2006; 13 (2): 6–29.

    Google Scholar 

  8. Wu Y, Huxley R, Li L, Anna V and China NNHS Steering Committee China NNHS Working Group. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 2008; 118 (25): 2679–2686.

    Article  Google Scholar 

  9. Liu XD, Gao B, Sun D, Shi M, Ma YY, Liu ZR et al. Prevalence of hyperhomocysteinaemia and some of its major determinants in Shaanxi Province, China: a cross-sectional study. Br J Nutr 2015; 113 (4): 691–698.

    Article  CAS  Google Scholar 

  10. Yang B, Fan S, Zhi X, Wang Y, Wang Y, Zheng Q et al. Prevalence of hyper- homocysteinemia in China: a systematic review and meta-analysis. Nutrients 2014; 7 (1): 74–90.

    Article  Google Scholar 

  11. Jiang Y, Xia X, Wang W, Lin L, Xu C, Cai Z et al. Hyperhomocysteinemia and related genetic polymorphisms correlate with ulcerative colitis in Chinese Han population in Central China [corrected]. Cell Biochem Biophys 2012; 62 (1): 203–210.

    Article  CAS  Google Scholar 

  12. Wang Y, Chen S, Yao T, Li D, Wang Y, Li Y et al. Homocysteine as a risk factor for hypertension: a 2-year follow-up study. Plos One 2014; 9 (10): e108223.

    Article  Google Scholar 

  13. Refsum H, Smiyh AD, Ueland PM, Nexo E, Clarke R, McPartlin J et al. Facts and recommendtions about total homocysteine determinations: all expert opinion. Clin CHem 2004; 50 (1): 3–32.

    Article  CAS  Google Scholar 

  14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.

    Article  CAS  Google Scholar 

  15. National Institute on Alcohol Abuse and Alcoholism. Health risks and benefits of alcohol consumption. Alcohol Res Health 2000; 24 (1): 5–11.

    Google Scholar 

  16. World Health Organization. Hypertension control: report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1996; 862: 1–883.

    Google Scholar 

  17. Nishida C, Uauy R, Kumanyika S, Shetty P . The joint WHO /FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr 2004; 7 (1A): 245–250.

    PubMed  Google Scholar 

  18. Expert Panel on Detection Evaluation,and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults(Adult Treatment Panel III). JAMA 2001; 285 (19): 2486–2497.

    Article  Google Scholar 

  19. World Health Organization and International Diabetes Fedaration Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. WHO: Geneva, 2006, 1–3.

  20. Panagiotakos DB, Pitsavos C, Chrysohoou C, Risvas G, Kontogianni MD, Zampelas A et al. Epidemiology of overweight and obesity in a Greek adult population: the ATTICA Study. Obes Res 2004; 12: 1914–1920.

    Article  Google Scholar 

  21. Chandalia M, Abate N, Cabo-Chan AV Jr, Devaraj S, Jialal I, Grundy SM . Hyperhomocysteinemia in Asian Indians living in the United States. J Clin Endocrinol Metab 2003; 88 (3): 1089–1095.

    Article  CAS  Google Scholar 

  22. de Bree A, van der Put NMJ, Mennen LI, Verschuren WMM . Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur J Clin Nutr 2005; 59: 480–488.

    Article  CAS  Google Scholar 

  23. Yu W, Xiaoying L, Xianhui Q, Yefeng C . Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45–75 year. Br J Nutr 2013; 109: 1284–1293.

    Article  Google Scholar 

  24. Ling H, Jing M, Jianghui Z, Meir J . High prevalence of hyperhomocysteinemia in chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 Status1. J Nutr 2007; 137 (2): 407–413.

    Article  Google Scholar 

  25. Spence JD, Stampfer MJ . Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses. JAMA 2011; 306 (23): 2610–2611.

    Article  CAS  Google Scholar 

  26. Qu QG, Gao JJ, Liu JM . Prevalence of hyperhomocysteinaemia in a Chinese elderly population. Public Health Nutr 2010; 13 (12): 1974–1981.

    Article  Google Scholar 

  27. Huang T, Tucker KL, Lee YC, Crott JW . Interactions between genetic variants of folate metabolism genes and lifestyle affect plasma homocysteine concentrations in the Boston Puerto Rican population. Public Health Nutr 2011; 14 (10): 1805–1812.

    Article  Google Scholar 

  28. Holmes MV, Newcombe P, Hubacek JA, Sofat R . Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 2011; 378 (9791): 584–594.

    Article  CAS  Google Scholar 

  29. Bart S Sr, Marr J, Diefenbach K, Trummer D . Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study. Contraception 2012; 85 (1): 42–50.

    Article  CAS  Google Scholar 

  30. Fukagawa NK, Martin JM, Wurthmann A, Pure AH . Sex-related differences in methionine metabolism and plasma homocysteine concentrations. Am J Clin Nutr 2000; 72: 22–29.

    Article  CAS  Google Scholar 

  31. El Mabchour A, Agueh V, Delisle H . Determinants and relationship of homocysteinemia with cardiometabolic risk factors. A study in Benin, West Africa. Presse Med 2010; 39 (11): e238–e246.

    Article  Google Scholar 

  32. Lu H, Lu ZH, Li PG, Wang YY, Yan ZY . Elevated homocysteine and hypertension in Xinjiang Province, China. Ethn Dis 2010; 20 (1): 7–10.

    PubMed  Google Scholar 

  33. Petr M, Steffl M, Kohlíková E . Effect of the MTHFR 677C/T polymorphism on homocysteinemia in response to creatine supplementation: a case study. Physiol Res 2013; 62 (6): 721–729.

    CAS  PubMed  Google Scholar 

  34. Gaikwad NW . Mass spectrometry evidence for formation of estrogen-homocysteine conjugates: estrogens can regulate homocysteine levels. Free Radic Biol Med 2013; 65: 1447–1454.

    Article  CAS  Google Scholar 

  35. Rogers EJ, Chen S, Chan A . Folate deficiency and plasma homocysteine during increased oxidative stress. N Engl J Med 2007; 357 (4): 421–422.

    Article  CAS  Google Scholar 

  36. Mazza A, Cuppini S, Schiavon L, Zuin M . Hyperhomocysteinemia is an independent predictor of sub-clinical carotid vascular damage in subjects with grade-1 hypertension. Endocrine 2014; 46 (2): 340–346.

    Article  CAS  Google Scholar 

  37. Cai W, Yin L, Yang F, Zhang L, Cheng J . Association between Hcy levels and the CBS844ins68 and MTHFR C677T polymorphisms with essentialhypertension. Biomed Rep 2014; 2 (6): 861–868.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from the ‘Twelfth Five-Year’ project funds (National Science and Technology Support Program of China, Grant no. 2012BAJ18B02), the Social Development Research Program of Liaoning Province (2013225089) and Natural Science Foundation of Liaoning Province (Grant no. 2013021090).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y Sun.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Z., Guo, X., Chen, S. et al. Hyperhomocysteinemia independently associated with the risk of hypertension: a cross-sectional study from rural China. J Hum Hypertens 30, 508–512 (2016). https://doi.org/10.1038/jhh.2015.75

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2015.75

  • Springer Nature Limited

This article is cited by

Navigation